James B. Renacci bought Supernus Pharmaceuticals Inc (NASDAQ: SUPN)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 3 trades in Supernus Pharmaceuticals Inc (SUPN) since 2017, 2 purchases and 1 sale, worth an estimated $49K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of Supernus Pharmaceuticals Inc (NASDAQ: SUPN) on November 27, 2017. Since that trade, SUPN is up +19.72% against the S&P 500 up +220.11%, an outperformance of -200.40%.
Across these filings, James B. Renacci has been a net buyer of SUPN (a buy-to-sell ratio of 2.00). The most recent disclosed SUPN transaction shown was dated December 15, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's SUPN trades vs the price
SUPN is up +19.72% since James B. Renacci bought on November 27, 2017, versus +220.11% for the S&P 500.
Performance since this trade
All James B. Renacci SUPN trades
James B. Renacci & SUPN trading FAQ
Is it legal for James B. Renacci to trade Supernus Pharmaceuticals Inc (SUPN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Supernus Pharmaceuticals Inc (SUPN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy SUPN?
James B. Renacci disclosed a purchase of $1,000 - $15,000 of Supernus Pharmaceuticals Inc (SUPN) on November 27, 2017, according to public STOCK Act filings.
How has SUPN performed since James B. Renacci's trade?
Since James B. Renacci bought SUPN on November 27, 2017, the stock is up +19.72%, versus +220.11% for the S&P 500 over the same period, an outperformance of -200.40%.
How many times has James B. Renacci traded SUPN?
James B. Renacci has disclosed 3 SUPN trades since 2017 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SUPN trades?
Quantellect tracks every disclosed congressional trade in Supernus Pharmaceuticals Inc (SUPN) on the Supernus Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's SUPN tradesAll congressional filings for Supernus Pharmaceuticals IncJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.